Skip to main content
. Author manuscript; available in PMC: 2017 Nov 13.
Published in final edited form as: FEBS Lett. 2015 Apr 11;589(11):1278–1282. doi: 10.1016/j.febslet.2015.03.036

Fig. 3.

Fig. 3

HAD activities of WT HN3, WT HN1, and amino acid-substituted HN3 glycoproteins for 23SD-RBCs. 23SD-RBCs were prepared by 23SD treatment of native RBCs for 30 (gray column), 45 (hatched column), or 60 min (empty column) at 37 °C. HAD activities of HN3 and HN1 glycoproteins for native RBCs (filled column) and 23SD-RBCs are represented as relative percentages to those of WT HN3 glycoprotein and WT HN1 glycoprotein for native RBCs, respectively.